Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Predictive Oncology Inc. - Common Stock (NQ:POAI)

0.8600 +0.0100 (+1.18%)
Streaming Delayed Price Updated: 3:48 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 234,088
Open 0.9200
Bid (Size) 0.8600 (100)
Ask (Size) 0.9000 (11)
Prev. Close 0.8500
Today's Range 0.8600 - 0.9600
52wk Range 0.5500 - 3.060
Shares Outstanding 4,063,081
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
POAI Reports Earnings
Via The Motley Fool
Topics Artificial Intelligence
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From Predictive Oncology Inc.
Via GlobeNewswire

Performance

YTD
-6.5%
-6.5%
1 Month
+9.5%
+9.5%
3 Month
-14.0%
-14.0%
6 Month
-55.9%
-55.9%
1 Year
-4.5%
-4.5%

More News

Read More
Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
From Predictive Oncology Inc.
Via GlobeNewswire
Court Denies Renovaro Motion for an Expedited Trial in July
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans Bullish
Via Stocktwits
Topics Artificial Intelligence Lawsuit
UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
From Predictive Oncology Inc.
Via GlobeNewswire
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
Via FinancialNewsMedia
Topics Artificial Intelligence
Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs
From Predictive Oncology Inc.
Via GlobeNewswire
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
From FN Media Group LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
Via FinancialNewsMedia
Topics Artificial Intelligence
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
From FN Media Group LLC
Via GlobeNewswire
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
From Predictive Oncology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Breakthroughs and Discoveries: TNON, PNPN.V, POAI, DYAI, PRSO, Drive Innovation Across Sectors
Via AB Newswire
Topics Artificial Intelligence
Top movers analysis one hour before the close of the markets on 2025-03-25: top gainers and losers in today's session.
Via Chartmill
Discover the most active stocks in Tuesday's session.
Via Chartmill
Which stocks are experiencing notable movement on Tuesday?
Via Chartmill

Frequently Asked Questions

Is Predictive Oncology Inc. - Common Stock publicly traded?
Yes, Predictive Oncology Inc. - Common Stock is publicly traded.
What exchange does Predictive Oncology Inc. - Common Stock trade on?
Predictive Oncology Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Predictive Oncology Inc. - Common Stock?
The ticker symbol for Predictive Oncology Inc. - Common Stock is POAI on the Nasdaq Stock Market
What is the current price of Predictive Oncology Inc. - Common Stock?
The current price of Predictive Oncology Inc. - Common Stock is 0.8600
When was Predictive Oncology Inc. - Common Stock last traded?
The last trade of Predictive Oncology Inc. - Common Stock was at 08/19/25 03:48 PM ET
What is the market capitalization of Predictive Oncology Inc. - Common Stock?
The market capitalization of Predictive Oncology Inc. - Common Stock is 3.49M
How many shares of Predictive Oncology Inc. - Common Stock are outstanding?
Predictive Oncology Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.